table of content
1 Study Coverage
1.1 Tianeptine Product Introduction
1.2 Market by Type
1.2.1 Global Tianeptine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Patent
1.2.3 Generic
1.3 Market by Application
1.3.1 Global Tianeptine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Depression and Anxiety
1.3.3 Irritable Bowel Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tianeptine Sales Estimates and Forecasts 2017-2028
2.2 Global Tianeptine Revenue Estimates and Forecasts 2017-2028
2.3 Global Tianeptine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tianeptine Sales by Region
2.4.1 Global Tianeptine Sales by Region (2017-2022)
2.4.2 Global Sales Tianeptine by Region (2023-2028)
2.5 Global Tianeptine Revenue by Region
2.5.1 Global Tianeptine Revenue by Region (2017-2022)
2.5.2 Global Tianeptine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tianeptine Sales by Manufacturers
3.1.1 Global Top Tianeptine Manufacturers by Sales (2017-2022)
3.1.2 Global Tianeptine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tianeptine in 2021
3.2 Global Tianeptine Revenue by Manufacturers
3.2.1 Global Tianeptine Revenue by Manufacturers (2017-2022)
3.2.2 Global Tianeptine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tianeptine Revenue in 2021
3.3 Global Tianeptine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tianeptine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tianeptine Sales by Type
4.1.1 Global Tianeptine Historical Sales by Type (2017-2022)
4.1.2 Global Tianeptine Forecasted Sales by Type (2023-2028)
4.1.3 Global Tianeptine Sales Market Share by Type (2017-2028)
4.2 Global Tianeptine Revenue by Type
4.2.1 Global Tianeptine Historical Revenue by Type (2017-2022)
4.2.2 Global Tianeptine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tianeptine Revenue Market Share by Type (2017-2028)
4.3 Global Tianeptine Price by Type
4.3.1 Global Tianeptine Price by Type (2017-2022)
4.3.2 Global Tianeptine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tianeptine Sales by Application
5.1.1 Global Tianeptine Historical Sales by Application (2017-2022)
5.1.2 Global Tianeptine Forecasted Sales by Application (2023-2028)
5.1.3 Global Tianeptine Sales Market Share by Application (2017-2028)
5.2 Global Tianeptine Revenue by Application
5.2.1 Global Tianeptine Historical Revenue by Application (2017-2022)
5.2.2 Global Tianeptine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tianeptine Revenue Market Share by Application (2017-2028)
5.3 Global Tianeptine Price by Application
5.3.1 Global Tianeptine Price by Application (2017-2022)
5.3.2 Global Tianeptine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tianeptine Market Size by Type
6.1.1 North America Tianeptine Sales by Type (2017-2028)
6.1.2 North America Tianeptine Revenue by Type (2017-2028)
6.2 North America Tianeptine Market Size by Application
6.2.1 North America Tianeptine Sales by Application (2017-2028)
6.2.2 North America Tianeptine Revenue by Application (2017-2028)
6.3 North America Tianeptine Market Size by Country
6.3.1 North America Tianeptine Sales by Country (2017-2028)
6.3.2 North America Tianeptine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Tianeptine Market Size by Type
7.1.1 Europe Tianeptine Sales by Type (2017-2028)
7.1.2 Europe Tianeptine Revenue by Type (2017-2028)
7.2 Europe Tianeptine Market Size by Application
7.2.1 Europe Tianeptine Sales by Application (2017-2028)
7.2.2 Europe Tianeptine Revenue by Application (2017-2028)
7.3 Europe Tianeptine Market Size by Country
7.3.1 Europe Tianeptine Sales by Country (2017-2028)
7.3.2 Europe Tianeptine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tianeptine Market Size by Type
8.1.1 Asia Pacific Tianeptine Sales by Type (2017-2028)
8.1.2 Asia Pacific Tianeptine Revenue by Type (2017-2028)
8.2 Asia Pacific Tianeptine Market Size by Application
8.2.1 Asia Pacific Tianeptine Sales by Application (2017-2028)
8.2.2 Asia Pacific Tianeptine Revenue by Application (2017-2028)
8.3 Asia Pacific Tianeptine Market Size by Region
8.3.1 Asia Pacific Tianeptine Sales by Region (2017-2028)
8.3.2 Asia Pacific Tianeptine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Tianeptine Market Size by Type
9.1.1 Latin America Tianeptine Sales by Type (2017-2028)
9.1.2 Latin America Tianeptine Revenue by Type (2017-2028)
9.2 Latin America Tianeptine Market Size by Application
9.2.1 Latin America Tianeptine Sales by Application (2017-2028)
9.2.2 Latin America Tianeptine Revenue by Application (2017-2028)
9.3 Latin America Tianeptine Market Size by Country
9.3.1 Latin America Tianeptine Sales by Country (2017-2028)
9.3.2 Latin America Tianeptine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tianeptine Market Size by Type
10.1.1 Middle East and Africa Tianeptine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tianeptine Revenue by Type (2017-2028)
10.2 Middle East and Africa Tianeptine Market Size by Application
10.2.1 Middle East and Africa Tianeptine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tianeptine Revenue by Application (2017-2028)
10.3 Middle East and Africa Tianeptine Market Size by Country
10.3.1 Middle East and Africa Tianeptine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tianeptine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Servier
11.1.1 Servier Corporation Information
11.1.2 Servier Overview
11.1.3 Servier Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Servier Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Servier Recent Developments
11.2 Lupin Limited
11.2.1 Lupin Limited Corporation Information
11.2.2 Lupin Limited Overview
11.2.3 Lupin Limited Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lupin Limited Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lupin Limited Recent Developments
11.3 PharmaS
11.3.1 PharmaS Corporation Information
11.3.2 PharmaS Overview
11.3.3 PharmaS Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 PharmaS Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PharmaS Recent Developments
11.4 Antibiotice
11.4.1 Antibiotice Corporation Information
11.4.2 Antibiotice Overview
11.4.3 Antibiotice Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Antibiotice Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Antibiotice Recent Developments
11.5 Serdia Pharmaceuticals
11.5.1 Serdia Pharmaceuticals Corporation Information
11.5.2 Serdia Pharmaceuticals Overview
11.5.3 Serdia Pharmaceuticals Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Serdia Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serdia Pharmaceuticals Recent Developments
11.6 Alvogen
11.6.1 Alvogen Corporation Information
11.6.2 Alvogen Overview
11.6.3 Alvogen Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Alvogen Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alvogen Recent Developments
11.7 Bausch Health
11.7.1 Bausch Health Corporation Information
11.7.2 Bausch Health Overview
11.7.3 Bausch Health Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bausch Health Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bausch Health Recent Developments
11.8 Genefar B.V.
11.8.1 Genefar B.V. Corporation Information
11.8.2 Genefar B.V. Overview
11.8.3 Genefar B.V. Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genefar B.V. Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genefar B.V. Recent Developments
11.9 Arena Pharmaceuticals
11.9.1 Arena Pharmaceuticals Corporation Information
11.9.2 Arena Pharmaceuticals Overview
11.9.3 Arena Pharmaceuticals Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Arena Pharmaceuticals Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Arena Pharmaceuticals Recent Developments
11.10 Glenmark
11.10.1 Glenmark Corporation Information
11.10.2 Glenmark Overview
11.10.3 Glenmark Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Glenmark Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Glenmark Recent Developments
11.11 Novartis
11.11.1 Novartis Corporation Information
11.11.2 Novartis Overview
11.11.3 Novartis Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Recent Developments
11.12 Dongwha Pharm
11.12.1 Dongwha Pharm Corporation Information
11.12.2 Dongwha Pharm Overview
11.12.3 Dongwha Pharm Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dongwha Pharm Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dongwha Pharm Recent Developments
11.13 Liconsa SA
11.13.1 Liconsa SA Corporation Information
11.13.2 Liconsa SA Overview
11.13.3 Liconsa SA Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Liconsa SA Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Liconsa SA Recent Developments
11.14 Mylan
11.14.1 Mylan Corporation Information
11.14.2 Mylan Overview
11.14.3 Mylan Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Mylan Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Mylan Recent Developments
11.15 Adamed
11.15.1 Adamed Corporation Information
11.15.2 Adamed Overview
11.15.3 Adamed Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Adamed Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Adamed Recent Developments
11.16 Neuraxpharm Arzneimittel
11.16.1 Neuraxpharm Arzneimittel Corporation Information
11.16.2 Neuraxpharm Arzneimittel Overview
11.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Neuraxpharm Arzneimittel Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Neuraxpharm Arzneimittel Recent Developments
11.17 Grupo Insud
11.17.1 Grupo Insud Corporation Information
11.17.2 Grupo Insud Overview
11.17.3 Grupo Insud Tianeptine Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Grupo Insud Tianeptine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Grupo Insud Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tianeptine Industry Chain Analysis
12.2 Tianeptine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tianeptine Production Mode & Process
12.4 Tianeptine Sales and Marketing
12.4.1 Tianeptine Sales Channels
12.4.2 Tianeptine Distributors
12.5 Tianeptine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tianeptine Industry Trends
13.2 Tianeptine Market Drivers
13.3 Tianeptine Market Challenges
13.4 Tianeptine Market Restraints
14 Key Findings in The Global Tianeptine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
